Biotech · Public company · Seattle, WA, US

Sana Biotechnology, Inc.

Ticker SANA · SEC CIK 0001770121

Track this companyFree. Adds Sana Biotechnology, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials44 recruiting or active

Pipeline programs3From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline3

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)PHASE1 · ACTIVE_NOT_RECRUITING · started Apr 29, 2024ClinicalTrials.gov NCT06294236 · fetched Nov 12, 2026
Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)PHASE1 · ACTIVE_NOT_RECRUITING · started Apr 18, 2024ClinicalTrials.gov NCT06285422 · fetched Nov 12, 2026
Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)PHASE1 · ACTIVE_NOT_RECRUITING · started May 2, 2023ClinicalTrials.gov NCT05878184 · fetched Nov 12, 2026
The Myelin Disorders Biorepository ProjectRECRUITING · started Dec 8, 2016ClinicalTrials.gov NCT03047369 · fetched Nov 12, 2026